Pharmazac has been named a Diamond Investor at Naftemporiki’s “Diamonds of the Greek Economy 2024 Awards”, a distinction recognising the company’s investment programme. The awards were […]
Pharmazac has a new head office. We are now based at 1, Anastasiou Zaroliagki & 6, Dimitriou Lamprou, Industrial Area GR-19001 Keratea, Greece, placing our head […]
Pharmazac launches the new product Cinacalcet/Pharmazac in 30mg, 60mg and 90mg F.C. Tablets. Cinacalcet indicated for the treatment of secondary Hyperparathyroidism (HPT) in adult patients with […]
We are welcoming KRKA in Greece and we are supporting them as their distributor! Pharmazac is happy to announce that this collaboration will start in December […]
We are becoming a manufacturer and key player in radiopharmaceuticals ! Pharmazac is happy to announce that its radiopharmaceuticals manufacturing unit in the industrial zone of […]
Pharmazac launches Zaolin, the first generic vinorelbin for oral use (soft caps) in Greece. Zaolin is a chemotherapy drug used to treat non-small cell lung cancer […]
Sugammadex is an intravenous medication given by doctors to rapidly reverse muscle relaxation caused by drugs like rocuronium and vecuronium after surgery. Pharmazac launches the 1st […]
Pharmazac launches the new product Apregalin® (pregabalin) for the treatment of peripheral and central neuropathic pain in adults, for epilepsy as adjunctive therapy in adults with […]
Pharmazac has just launched the new product Vasitimb (ezetimibe + simvastatin) for the prevention of cardiovascular events, for hypercholesterlaemia and the Homozygous Familial Hypercholesterolaemia. Vasitimb is indicated […]